Integrated Genomic Profiling Identifies Loss of Chromosome 11p Impacting Transcriptomic Activity in Aggressive Pituitary PRL Tumors-Reference-Cited by-同舟云学术

Integrated Genomic Profiling Identifies Loss of Chromosome 11p Impacting Transcriptomic Activity in Aggressive Pituitary PRL Tumors

Published:2011-02-23 Issue: Volume: Page:no-no
ISSN:1015-6305
Container-title:Brain Pathology
language:en
Short-container-title:

Author:

Wierinckx Anne,Roche Magali,Raverot Gérald,Legras-Lachuer Catherine,Croze Séverine,Nazaret Nicolas,Rey Catherine,Auger Carole,Jouanneau Emmanuel,Chanson Philippe,Trouillas Jacqueline,Lachuer Joël

Publisher

Wiley

Subject

Clinical Neurology,Pathology and Forensic Medicine,General Neuroscience

Reference45 articles.

1. The pathogenesis of pituitary tumors;Asa;Annu Rev Pathol,2009

2. Identification of metastasis-related microRNAs in hepatocellular carcinoma;Budhu;Hepatology,2008

3. An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer;Chari;BMC Syst Biol,2010

4. A positive feedback loop couples Ras activation and CD44 alternative splicing;Cheng;Genes Dev,2006

5. Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile;Cifola;Mol Cancer,2008

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell transcriptomic analysis reveals tumor cell heterogeneity and immune microenvironment features of pituitary neuroendocrine tumors;Genome Medicine;2024-01-02

2. Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas;Frontiers in Endocrinology;2023-07-17

3. Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment;The Journal of Clinical Endocrinology & Metabolism;2023-02-28

4. The hallmarks of cancer… in pituitary tumors?;Reviews in Endocrine and Metabolic Disorders;2022-12-31

5. MicroRNA-137 inhibits pituitary prolactinoma proliferation by targeting AKT2;Journal of Endocrinological Investigation;2022-11-24